[Nitrate derivatives and anesthesia-resuscitation: physiopathologic bases and therapeutic indications].
This review briefly describes the cellular mechanisms of nitrates and the tolerance. Nitrates activate NO production thus GMPc in the smooth muscle cell explaining their vasodilating properties even in absence of an intact endothelium. The biologic pathway of AMPc is stimulated by prostaglandin activated by nitrates. Tolerance to these agents could result from depletion of sulfhydryl radical but also from reflex cardiovascular adaptation. After a brief recall of pharmacokinetic, pharmacodynamic properties are detailed. Therapeutic use in cardiac surgery, non-cardiac surgery, controlled hypotension, aortic surgery, heart failure, unstable angina, myocardial infarction and systolic hypertension in the elderly are discussed.
Beloucif
S
S
Département d'Anesthésie-Réanimation, Hôpital Lariboisière, Paris.
Beloucif
L
L
Payen
D
D
D000758:Anesthesia; D004361:Drug Tolerance; D006801:Humans; D005996:Nitroglycerin / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D009599:Nitroprusside / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D012151:Resuscitation
D009599:Nitroprusside; D005996:Nitroglycerin
Dérivés nitrés et anesthésie-réanimation: bases physiopathologiques et indications thérapeutiques.